Clinical Trial: A Phase III Study To Evaluate the Efficacy And Safety Of SHR-1918 In Participants With Hypertriglyceridemia

U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07349615) titled 'A Phase III Study To Evaluate the Efficacy And Safety Of SHR-1918 In Participants With Hypertriglyceridemia' on Jan. 13.

Brief Summary: The purpose of the study is to evaluate the efficacy and safety of SHR-1918 in patients with hypertriglyceridemia. The efficacy and safety of SHR-1918 will be evaluated after 24-weeks and 48-weeks treatment.

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Hypertriglyceridemia

Intervention: DRUG: SHR-1918/ SHR-1918 placebo

SHR-1918/ SHR-1918 placebo Dose 1

DRUG: SHR-1918/ SHR-1918 placebo

SHR-1918/ SHR-1918 placebo Dose 2

Recruitment Status: NOT_YET_RECRUITING

Sponsor: B...